Total Holdings
68
As of Oct 4, 2026
Virtus Biotech ETF
BBPNYSEARCAVirtus Investment PartnersEquity
$100.15Today:- (-)1Y +45.11%
As of Oct 16, 2026 close
- Assets (AUM)
- $128.74M
- Expense ratio
- 0.34%
- Dividend yield
- -
- Holdings
- 68
- 52-week range
- $71.65$110.05
- Volume (live)
- -
- Avg. volume (3M)
- 14.10K
BBP ETF Holdings: Virtus Biotech ETF
Every listed position with its portfolio weight, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Top 10 Holdings
27.4%
Share of fund assets
Assets (AUM)
$128.74M
Total fund assets
Expense Ratio
0.34%
Annual management fee
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 of 68 BBP Holdings by Portfolio Weight
Holdings as of Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 50 positions.
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Moderna, Inc | Stock | 5.14% |
| 2 |  | Iovance Biotherapeutics, Inc. | Stock | 4.58% |
| 3 |  | Omeros Corporation | Stock | 2.96% |
| 4 |  | Precigen, Inc. | Stock | 2.52% |
| 5 |  | Verastem, Inc. | Stock | 2.47% |
| 6 |  | Halozyme Therapeutics, Inc | Stock | 2.11% |
| 7 |  | Kiniksa Pharmaceuticals International, plc | Stock | 1.92% |
| 8 |  | ImmunityBio, Inc. | Stock | 1.91% |
| 9 |  | Rigel Pharmaceuticals Inc | Stock | 1.89% |
| 10 |  | Zai Lab Limited | Stock | 1.89% |
| 11 |  | BeOne Medicines AG | Stock | 1.78% |
| 12 |  | Xeris Biopharma Holdings, Inc. | Stock | 1.76% |
| 13 | BGNE | BeiGene, Ltd | Stock | 1.76% |
| 14 |  | Protagonist Therapeutics, Inc. | Stock | 1.68% |
| 15 |  | Regeneron Pharmaceuticals, Inc | Stock | 1.66% |
| 16 |  | Tarsus Pharmaceuticals Inc | Stock | 1.58% |
| 17 |  | Sarepta Therapeutics, Inc | Stock | 1.57% |
| 18 |  | Roivant Sciences Ltd. | Stock | 1.56% |
| 19 |  | ADMA Biologics, Inc. | Stock | 1.56% |
| 20 |  | Ligand Pharmaceuticals Incorporated | Stock | 1.56% |
| 21 |  | Insmed Incorporated | Stock | 1.55% |
| 22 |  | Novavax, Inc. | Stock | 1.55% |
| 23 |  | Kura Oncology, Inc. | Stock | 1.55% |
| 24 |  | Gilead Sciences, Inc | Stock | 1.55% |
| 25 |  | Harmony Biosciences Holdings Inc | Stock | 1.54% |
| 26 | NK | NantKwest Inc | Stock | 1.53% |
| 27 |  | Vertex Pharmaceuticals Incorporated | Stock | 1.53% |
| 28 |  | Amgen Inc | Stock | 1.51% |
| 29 |  | Nuvation Bio Inc | Stock | 1.50% |
| 30 |  | TG Therapeutics, Inc | Stock | 1.50% |
| 31 |  | Travere Therapeutics Inc | Stock | 1.47% |
| 32 |  | Incyte Corporation | Stock | 1.47% |
| 33 |  | Biogen Inc | Stock | 1.47% |
| 34 |  | Ironwood Pharmaceuticals, Inc | Stock | 1.46% |
| 35 |  | Rhythm Pharmaceuticals, Inc | Stock | 1.44% |
| 36 |  | Agios Pharmaceuticals, Inc | Stock | 1.43% |
| 37 |  | Arcutis Biotherapeutics, Inc | Stock | 1.42% |
| 38 |  | Geron Corporation | Stock | 1.41% |
| 39 |  | Exelixis, Inc | Stock | 1.41% |
| 40 |  | CRISPR Therapeutics AG | Stock | 1.40% |
| 41 |  | BioNTech SE | Stock | 1.40% |
| 42 |  | Krystal Biotech, Inc | Stock | 1.40% |
| 43 |  | BioMarin Pharmaceutical Inc | Stock | 1.39% |
| 44 |  | Madrigal Pharmaceuticals, Inc | Stock | 1.39% |
| 45 |  | Immunocore Holdings plc | Stock | 1.37% |
| 46 |  | Ascendis Pharma AS | Stock | 1.33% |
| 47 |  | Syndax Pharmaceuticals Inc | Stock | 1.29% |
| 48 |  | BioCryst Pharmaceuticals Inc | Stock | 1.27% |
| 49 |  | BridgeBio Pharma, Inc | Stock | 1.27% |
| 50 |  | ACADIA Pharmaceuticals Inc | Stock | 1.26% |
Source: Fund holdings disclosures. Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About Virtus Biotech ETF Holdings
What are the top holdings in BBP?
As of Oct 4, 2026, Virtus Biotech ETF (BBP) holds 68 securities. The largest are Moderna, Inc (5.14%), Iovance Biotherapeutics, Inc. (4.58%), Omeros Corporation (2.96%). The holdings table lists each position by portfolio weight with its ticker, name and asset type.
How concentrated is BBP's portfolio?
As of Oct 4, 2026, the 10 largest positions make up 27.4% of BBP's assets. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly.
What is BBP's sector allocation?
The Sector Allocation chart shows how BBP distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does BBP invest in?
BBP's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is BBP ETF?
BBP's diversification can be assessed by reviewing its 68 holdings (as of Oct 4, 2026), sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.